Nivolumab,Ipilimumab
BMS
[]
long-term survival benefit is seen in patients with treatment-na ve advanced esophageal squamous cell carcinoma who were treated with nivolumab plus chemotherapy or ipilimumab. #gicsm #gi23 | 
Home of the journal ONCOLOGY®, CancerNetwork® offers different perspectives on oncology/hematology through review articles, news, podcasts, blogs, and more.